The defense rested in the 2nd Vioxx product liability trial after defendant Merck & Co. presented a cardiology expert as its final witness.
The last witness was Dr. John Michael Gaziano, a Harvard Medical School professor. Surprise surprise, he testified that he believes there is no link between Vioxx and heart attacks - even with long-term use.
Instructions Thursday.
